TY  - JOUR
T1  - Coronary events with lipid-lowering therapy: The afcaps/texcaps trial
AU  - Walsh J
Y1  - 1999/02/03
N1  - 10-1001/pubs.JAMA-ISSN-0098-7484-281-5-jbk0203
JO  - JAMA
SP  - 414
EP  - 419
VL  - 281
IS  - 5
N2  - 
Because the CHD event rate in women is lower than in men at any given
age, many more women than men must be treated to prevent 1 CHD event.
The authors report that if "1000 men and women were treated with
lovastatin for 5 years, approximately 19 acute major coronary events
(12 myocardial infarctions and
7 presentations of unstable angina) and 17
coronary revascularizations could be prevented."

SN  - 0098-7484
M3  - doi: 10-1001/pubs.JAMA-ISSN-0098-7484-281-5-jbk0203
UR  - http://dx.doi.org/10-1001/pubs.JAMA-ISSN-0098-7484-281-5-jbk0203
ER  -